Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria

This publication has 10 references indexed in Scilit:

• Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria
  Kidney International, 2005
• Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease
  Diabetes Care, 2004
• An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting
  Journal of Human Hypertension, 2004
• Gesundheitsökonomische Aspekte der Anwendung von Irbesartan bei Patienten mit Typ-2-Diabetes, Nephropathie und Hypertonie in Deutschland
  Deutsche Medizinische Wochenschrift (1946), 2004
• An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings
  Nephrology Dialysis Transplantation, 2003
• The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy
  Clinical Therapeutics, 2003
• The Contribution of Increased Diabetes Prevalence and Improved Myocardial Infarction and Stroke Survival to the Increase in Treated End-Stage Renal Disease
  Journal of the American Society of Nephrology, 2003
• The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
  New England Journal of Medicine, 2001
• Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
  New England Journal of Medicine, 2001
• Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management
  Journal of Human Hypertension, 2000